Therapeutic applications of drugs acting on peripheral dopamine receptors. - Wikidata - awgldk - TriplyDB

Therapeutic applications of drugs acting on peripheral dopamine receptors.

Therapeutic applications of drugs acting on peripheral dopamine receptors.

http://www.wikidata.org/entity/Q37598885

about

The role of dopaminergic agonists in congestive heart failure.Experimental study of the detrimental effect of dopamine/glucagon combination in d,l-propranolol intoxication.Effects of dopaminergic drugs on inflammatory bowel disease induced with 2,4-dinitrofluorbenzene in BALB/c mice.

P2860

Q41348359-09010930-F4FB-46BB-B2B8-0E4A21528E88 Q43691346-F264B148-2562-4AE8-884C-E8DAFDA63C1B Q43736163-4A8C957A-2500-4441-8617-74876D7A5FF6

P2860

Therapeutic applications of drugs acting on peripheral dopamine receptors.

http://www.wikidata.org/entity/Q37598885

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 1990

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Therapeutic applications of drugs acting on peripheral dopamine receptors.

@en

Therapeutic applications of drugs acting on peripheral dopamine receptors.

@nl

type

label

Therapeutic applications of drugs acting on peripheral dopamine receptors.

@en

Therapeutic applications of drugs acting on peripheral dopamine receptors.

@nl

prefLabel

Therapeutic applications of drugs acting on peripheral dopamine receptors.

@en

Therapeutic applications of drugs acting on peripheral dopamine receptors.

@nl

P1433

Q37598885-B9D3FA4B-5CA2-487A-B557-CF58716CBFF5

P1476

Q37598885-AE61FF69-920C-4E70-964A-DBA0C8A5A31D

P2093

Q37598885-8B8F2ABB-A3BC-4A16-ACE0-74E9F73F465A

Q37598885-8E0FFE07-2275-4AD1-AF89-CCF289CAEA60

P2860

Q37598885-004AEF1C-5D17-46C8-A453-C63D2E6AD9EF

Q37598885-078F00D3-599A-4371-95F6-59F3BA8A8CBE

Q37598885-0D1FC714-D8F3-4B75-A8B1-A0FDFFBE2CB7

Q37598885-1BFC9004-234D-4A90-A724-314ED241EEFC

Q37598885-1CC5BDD9-F52F-4D10-86D6-928870CA20F2

Q37598885-418D5B81-71C6-4023-B17E-78F420565606

Q37598885-4A4E0B46-1648-44C0-8D2F-28A9A6B3998B

Q37598885-4C7A8C41-6C73-428A-B8FB-6D9254524229

Q37598885-6B08BD7C-56D8-4C4D-B742-8F66B827EAFC

Q37598885-73CE771B-3E20-42AC-8ACB-65F6D25603B7

P304

Q37598885-6ADA452A-AB46-401F-B0A5-E2039FF2C6A1

P31

Q37598885-21B58BB8-D9F3-4550-9AC9-BC5AF01D31AF

P356

Q37598885-C11DA6FD-A4E2-404A-AF2B-71C05FBCE172

P433

Q37598885-B2744420-BCD1-4DC6-B691-4DC548C8A497

P478

Q37598885-80ACFA6D-7784-428D-A387-A2B911A2FDA1

P577

Q37598885-34137D39-5E2C-47DB-88D5-10D7F5696D1F

P698

Q37598885-80070D70-71F3-4D32-8552-2B33AEB55161

P921

Q37598885-947f1396-f9f3-4012-aedd-409cf836f00e

P356

J.1552-4604.1990.TB03625.X

P1433

The Journal of Clinical Pharmacology

P1476

Therapeutic applications of drugs acting on peripheral dopamine receptors.

@en

P2093

Horn PT

http://www.w3.org/2001/XMLSchema#string

Murphy MB

http://www.w3.org/2001/XMLSchema#string

P2860

Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors

Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels

Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension

(+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.

Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.

Metabolism of gamma-glutamyl amino acids and peptides in mouse liver and kidney in vivo.

Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.

Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Minoxidil: a review of its pharmacological properties and therapeutic use.

Reversal by the selective D-2 dopamine receptor blocker sulpiride of the hypotensive effect of co-dergocrine in elderly hypertensives.

P304

674-679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1552-4604.1990.TB03625.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1990-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1976128

http://www.w3.org/2001/XMLSchema#string

P921